Spectrum of BRAF Mutations and Gene Rearrangements in Ovarian Serous Carcinoma.
Michael Herman ChuiJason C ChangYanming ZhangAhmet ZehirAlison M SchramJason A KonnerAlexander E DrilonArnaud Da Cruz PaulaJorge S Reis-FilhoRachel N GrishamPublished in: JCO precision oncology (2021)
Recognition of BRAF alterations beyond V600E mutation in LGSC may have clinical implications for appropriate targeted therapy selection.